Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Director departure
Quarterly results
GENTA INC DE (GNTA) Create: Alert

All | News | Filings
Date FiledTypeDescription
06/18/2012 GN Genta Announces Agreement With FDA on Special Protocol Assessment of Phase 3 Trial of Tesetaxel as Initial Chemotherapy for Women With Metastatic Breast Cancer
06/18/2012 GN Genta Incorporated to Present at 2012 BIO International
05/31/2012 GN Genta Initiates Randomized Trial of Tesetaxel as First-Line Therapy for Women With Recurrent Breast Cancer
05/22/2012 GN Tesetaxel Results as Initial Chemotherapy for Women With Recurrent Breast Cancer to be Highlighted at ASCO
05/14/2012 GN Genta Incorporated Reports First Quarter 2012 Financial Results
05/08/2012 GN Genta Initiates Randomized Trial of Tesetaxel in Gastric Cancer
04/24/2012 GN Genta Appoints Dr. Brian Leyland-Jones and Richard J. Moran to Its Board of Directors
02/06/2012 GN Genta Incorporated to Present at 14th Annual BIO CEO ' Investor Conference
01/19/2012 GN New Clinical Trial Confirms the Activity of Tesetaxel in Patients With Advanced Gastric Cancer
01/03/2012 GN Genta Incorporated to Present at the 5th Annual OneMedForum in San Francisco
12/08/2011 GN Genta Announces Results From Clinical Trial of Tesetaxel as Initial Chemotherapy for Women With Recurrent Breast Cancer

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy